<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Transketolase-like 1 (TKTL1) induces <z:chebi fb="105" ids="17234">glucose</z:chebi> degradation through anaerobic pathways, even in presence of oxygen, favoring the malignant aerobic glycolytic phenotype characteristic of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="1" pm="."><plain>As TKTL1 appears to be a valid biomarker for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prognosis, the aim of the current study was to correlate its expression with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage, probability of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> recurrence and survival, in a series of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>METHODOLODY/PRINCIPAL FINDINGS: <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> tissues from 63 patients diagnosed with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> at different stages of progression were analyzed for TKTL1 by immunohistochemistry </plain></SENT>
<SENT sid="3" pm="."><plain>Staining was quantified by computational image analysis, and correlations between enzyme expression, local growth, lymph-node involvement and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> were assessed </plain></SENT>
<SENT sid="4" pm="."><plain>The highest values for TKTL1 expression were detected in the group of stage III <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, which showed significant differences from the other groups (Kruskal-Wallis test, P = 0.000008) </plain></SENT>
<SENT sid="5" pm="."><plain>Deeper analyses of T, N and M classifications revealed a weak correlation between local <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and enzyme expression (Mann-Whitney test, P = 0.029), a significant association of the enzyme expression with lymph-node involvement (Mann-Whitney test, P = 0.0014) and a significant decrease in TKTL1 expression associated with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (Mann-Whitney test, P = 0.0004) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS/SIGNIFICANCE: To our knowledge, few studies have explored the association between variations in TKTL1 expression in the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> formation </plain></SENT>
<SENT sid="7" pm="."><plain>Here we report downregulation of enzyme expression when <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> appears, and a correlation between enzyme expression and regional lymph-node involvement in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>This finding may improve our understanding of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and lead to new and more efficient therapies against <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>